Literature DB >> 21478824

Expression of FOXL2 in human normal pituitaries and pituitary adenomas.

Noboru Egashira1, Susumu Takekoshi, Mao Takei, Akira Teramoto, Robert Y Osamura.   

Abstract

Many transcription factors have important roles in the function and differentiation of the human pituitary adenomas. Forkhead box gene transcription factor L2, Foxl2, is expressed during mouse pituitary development and co-localizes with the expression of α-glycoprotein hormone subunit (αGSU). In addition, Foxl2 regulates expression of the αGSU gene (Cga) in cell culture. To elucidate the functional role of FOXL2 in the human pituitary, we examined the expression and localization of FOXL2 in normal human pituitaries and various types of pituitary adenomas. Human pituitary adenomas were obtained by trans-sphenoidal surgery from 67 patients. Three normal adult pituitaries were obtained from autopsies of non-endocrine cases. The localization of FOXL2 and pituitary hormones in these pituitary patients was examined by immunohistochemical staining and RT-PCR. Quantitative analysis of FOXL2 protein was performed by immunoblotting. FOXL2 was localized in the nuclei of ∼20% of normal pituitary cells that also co-expressed gonadotropins including follicule-stimulating hormone β (FSHβ), luteinizing hormone β (LHβ), and αGSU, whereas it was observed in minor proportion of thyroid-stimulating hormone (TSH)-producing cells, prolactin (PRL)-producing cells, and precursor of adrenocorticotropic hormone (ACTH)-producing cells. FOXL2 immunoreactivity was not detected in growth hormone (GH)-producing cells or S100-positive folliculo-stellate cells. In human pituitary adenomas, FOXL2 was expressed in the nuclei of the adenoma cells. FOXL2 was detected in 13 of 15 gonadotropin-subunit-producing adenoma (Gn-oma) cases and 8 of 11 null cell adenoma cases, but its incidence was reduced or not detected in the other types of adenomas. The results of this study suggest that FOXL2 contributes to the human-specific functional expression and the differentiation of gonadotroph cells and adenomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478824     DOI: 10.1038/modpathol.2010.169

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

Review 1.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

2.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

Review 3.  Minireview: Activin Signaling in Gonadotropes: What Does the FOX say… to the SMAD?

Authors:  Jérôme Fortin; Luisina Ongaro; Yining Li; Stella Tran; Pankaj Lamba; Ying Wang; Xiang Zhou; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2015-05-05

4.  Increased FOXL2 expression alters uterine structures and functions†.

Authors:  Rong Li; San-Pin Wu; Lecong Zhou; Barbara Nicol; John P Lydon; Humphrey H-C Yao; Francesco J DeMayo
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

Review 5.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

6.  Impaired fertility and FSH synthesis in gonadotrope-specific Foxl2 knockout mice.

Authors:  Stella Tran; Xiang Zhou; Christine Lafleur; Michael J Calderon; Buffy S Ellsworth; Sarah Kimmins; Ulrich Boehm; Mathias Treier; Derek Boerboom; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2013-01-22

7.  Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2.

Authors:  Jérôme Fortin; Ulrich Boehm; Chu-Xia Deng; Mathias Treier; Daniel J Bernard
Journal:  FASEB J       Date:  2014-04-16       Impact factor: 5.191

8.  Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Cuiqi Zhou; Anat Ben-Shlomo; Kolja Wawrowsky; Yoel Toledano; Yunguang Tong; Kalman Kovacs; Bernd Scheithauer; Shlomo Melmed
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

9.  Let-7b/c enhance the stability of a tissue-specific mRNA during mammalian organogenesis as part of a feedback loop involving KSRP.

Authors:  Emanuela Repetto; Paola Briata; Nathalie Kuziner; Brian D Harfe; Michael T McManus; Roberto Gherzi; Michael G Rosenfeld; Michele Trabucchi
Journal:  PLoS Genet       Date:  2012-07-26       Impact factor: 5.917

10.  Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.

Authors:  Stefano Pierini; Janos L Tanyi; Fiona Simpkins; Erin George; Mireia Uribe-Herranz; Ronny Drapkin; Robert Burger; Mark A Morgan; Andrea Facciabene
Journal:  JCI Insight       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.